Trial intelligence / Profile preview

Effects of Sildenafil on Choroidal Thickness in AMD

NCT01830790Phase 2Terminated

Sponsor
Duke University
Start
Mar 2013
Primary completion
May 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of sildenafil in age-related macular degeneration (AMD), sponsored by Duke University. Started Mar 2013; status: terminated.

02

Drugs

sildenafil
03

Conditions

age-related macular degeneration (AMD)

Beyond the preview

Go deeper on NCT01830790.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01830790.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call